Developing Reproducible Small Animal Models to Better Reflect Lung Fibrosis Pathophysiology

Developing Reproducible Small Animal Models to Better Reflect Lung Fibrosis PathophysiologyПодробнее

Exploring the Basic Mechanisms that Contribute to Development of Lung FibrosisПодробнее

Clinically Relevant Animal Models of FibrosisПодробнее

Understanding the Complexity of in vitro Models in Therapeutic Development | Madhu Lal-NagПодробнее

Preclinical Models of Lung Inflammatory DiseaseПодробнее

Automated in Vivo Efficacy Assessment in Preclinical Lung Disease ModelsПодробнее

Objective quantitative evaluation of anti fibrotic agents in animal modelsПодробнее

Advancing models of lung health and disease through interdisciplinary collaborations.Подробнее

Red in Motion: How MSCs Work to Alleviate Pulmonary FibrosisПодробнее

Human Lung Tissue Implanted on the Chick Chorioallantoic MembraneПодробнее

NACFC 2021 | W12: Models to Better Understand Cystic Fibrosis Pathogenesis and BiologyПодробнее

Post COVID FibrosisПодробнее

Preclinical Mouse Models of Pulmonary DiseaseПодробнее

Dr Anna Cieślak: Modeling fibrotic lung disease using human pluripotent stem cells (13th Aug 2020)Подробнее

The Progressive Phenotype of Non-IPF ILD: Clinical Relevance and IdentificationПодробнее

Clinical Trials in the Era of Effective Therapies | Luca Richeldi, MD, PhDПодробнее

These patients can NEVER meet in real life 💔☠️ Doctor explains Cystic FibrosisПодробнее

QSP Modeling of Fibrosis in Liver, Lung, and HeartПодробнее

Novel Therapeutics for Fibrotic Disease: Has Their Time Finally Arrived?Подробнее